AORT
Price
$30.81
Change
-$0.56 (-1.79%)
Updated
Jan 31, 04:25 PM (EDT)
Capitalization
873.56M
13 days until earnings call
ELMD
Price
$34.56
Change
-$0.58 (-1.65%)
Updated
Jan 31, 04:29 PM (EDT)
Capitalization
139.58M
18 days until earnings call
Ad is loading...

AORT vs ELMD

Header iconAORT vs ELMD Comparison
Open Charts AORT vs ELMDBanner chart's image
Artivion
Price$30.81
Change-$0.56 (-1.79%)
Volume$200
Capitalization873.56M
Electromed
Price$34.56
Change-$0.58 (-1.65%)
Volume$200
Capitalization139.58M
AORT vs ELMD Comparison Chart
Loading...
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AORT vs. ELMD commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AORT is a Buy and ELMD is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Jan 31, 2025
Stock price -- (AORT: $31.37 vs. ELMD: $35.14)
Brand notoriety: AORT and ELMD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AORT: 122% vs. ELMD: 63%
Market capitalization -- AORT: $873.56M vs. ELMD: $139.58M
AORT [@Medical Specialties] is valued at $873.56M. ELMD’s [@Medical Specialties] market capitalization is $139.58M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AORT’s FA Score shows that 0 FA rating(s) are green whileELMD’s FA Score has 2 green FA rating(s).

  • AORT’s FA Score: 0 green, 5 red.
  • ELMD’s FA Score: 2 green, 3 red.
According to our system of comparison, ELMD is a better buy in the long-term than AORT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AORT’s TA Score shows that 4 TA indicator(s) are bullish while ELMD’s TA Score has 2 bullish TA indicator(s).

  • AORT’s TA Score: 4 bullish, 5 bearish.
  • ELMD’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, both AORT and ELMD are a bad buy in the short-term.

Price Growth

AORT (@Medical Specialties) experienced а +2.45% price change this week, while ELMD (@Medical Specialties) price change was +5.53% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.50%. For the same industry, the average monthly price growth was +6.01%, and the average quarterly price growth was +7.48%.

Reported Earning Dates

AORT is expected to report earnings on May 01, 2025.

ELMD is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Medical Specialties (+0.50% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AORT($874M) has a higher market cap than ELMD($140M). AORT has higher P/E ratio than ELMD: AORT (434.78) vs ELMD (36.04). ELMD YTD gains are higher at: 18.917 vs. AORT (9.724). AORT has higher annual earnings (EBITDA): 26.8M vs. ELMD (5.81M). AORT has more cash in the bank: 58.9M vs. ELMD (10.4M). ELMD has less debt than AORT: ELMD (1.09M) vs AORT (358M). AORT has higher revenues than ELMD: AORT (354M) vs ELMD (51.7M).
AORTELMDAORT / ELMD
Capitalization874M140M624%
EBITDA26.8M5.81M461%
Gain YTD9.72418.91751%
P/E Ratio434.7836.041,206%
Revenue354M51.7M685%
Total Cash58.9M10.4M566%
Total Debt358M1.09M32,874%
FUNDAMENTALS RATINGS
AORT vs ELMD: Fundamental Ratings
AORT
ELMD
OUTLOOK RATING
1..100
2076
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
97
Overvalued
PROFIT vs RISK RATING
1..100
789
SMR RATING
1..100
8953
PRICE GROWTH RATING
1..100
3935
P/E GROWTH RATING
1..100
8211
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AORT's Valuation (94) in the Medical Specialties industry is in the same range as ELMD (97). This means that AORT’s stock grew similarly to ELMD’s over the last 12 months.

ELMD's Profit vs Risk Rating (9) in the Medical Specialties industry is significantly better than the same rating for AORT (78). This means that ELMD’s stock grew significantly faster than AORT’s over the last 12 months.

ELMD's SMR Rating (53) in the Medical Specialties industry is somewhat better than the same rating for AORT (89). This means that ELMD’s stock grew somewhat faster than AORT’s over the last 12 months.

ELMD's Price Growth Rating (35) in the Medical Specialties industry is in the same range as AORT (39). This means that ELMD’s stock grew similarly to AORT’s over the last 12 months.

ELMD's P/E Growth Rating (11) in the Medical Specialties industry is significantly better than the same rating for AORT (82). This means that ELMD’s stock grew significantly faster than AORT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AORTELMD
RSI
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
71%
Momentum
ODDS (%)
Bullish Trend 3 days ago
70%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
75%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
72%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 26 days ago
68%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
70%
Aroon
ODDS (%)
Bearish Trend 3 days ago
66%
Bullish Trend 3 days ago
76%
View a ticker or compare two or three
Ad is loading...
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JMVCX15.910.17
+1.08%
Janus Henderson Mid Cap Value C
LCEVX18.470.12
+0.65%
Invesco Diversified Dividend C
MXCCX7.21N/A
N/A
Federated Hermes Max-Cap Index C
PCMRX23.49N/A
N/A
Pioneer Mid Cap Value R
RBRCX14.30N/A
N/A
RBC Small Cap Core R6

AORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, AORT has been loosely correlated with SIBN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AORT jumps, then SIBN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AORT
1D Price
Change %
AORT100%
+0.48%
SIBN - AORT
45%
Loosely correlated
-1.05%
SONVY - AORT
42%
Loosely correlated
+0.53%
KIDS - AORT
41%
Loosely correlated
-2.82%
LIVN - AORT
40%
Loosely correlated
-0.18%
LMAT - AORT
40%
Loosely correlated
+0.23%
More

ELMD and

Correlation & Price change

A.I.dvisor tells us that ELMD and CORBF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELMD and CORBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELMD
1D Price
Change %
ELMD100%
-0.82%
CORBF - ELMD
27%
Poorly correlated
-0.99%
IQV - ELMD
27%
Poorly correlated
+1.87%
CRL - ELMD
26%
Poorly correlated
+2.43%
INFU - ELMD
22%
Poorly correlated
-1.93%
AORT - ELMD
22%
Poorly correlated
+0.48%
More